ChE

Cholinesterase

Liver Function

What is Cholinesterase?

Cholinesterase refers to two related enzymes: acetylcholinesterase (AChE, also called "true" cholinesterase), found primarily in red blood cells and nerve synapses, and butyrylcholinesterase (BChE, also called pseudocholinesterase or serum cholinesterase), produced by the liver and found in plasma. In clinical practice, "serum cholinesterase" almost always refers to butyrylcholinesterase. Both enzymes hydrolyze choline esters, but they differ in substrate specificity, tissue distribution, and clinical significance.

Serum cholinesterase (BChE) is a sensitive marker of the liver's synthetic capacity. Because it is produced exclusively by the liver and has a half-life of approximately 12 days, declining levels reliably indicate deteriorating hepatic function. It falls earlier than albumin in acute liver disease and can help distinguish liver conditions from other causes of abnormal liver tests. Additionally, cholinesterase measurement is critically important in two clinical settings: evaluating suspected organophosphate or nerve agent poisoning (where both AChE and BChE are inhibited) and pre-surgical screening for pseudocholinesterase deficiency, a genetic condition that causes prolonged paralysis after administration of succinylcholine.

Why It Matters

Cholinesterase serves dual clinical roles: as a highly sensitive indicator of liver synthetic function and as a critical marker in toxicology. In liver disease, a falling cholinesterase level indicates worsening synthetic capacity and is prognostically significant. In organophosphate poisoning—a common agricultural and chemical warfare exposure—rapid measurement of cholinesterase guides the urgency of treatment with atropine and pralidoxime. Preoperative identification of pseudocholinesterase deficiency prevents potentially fatal prolonged paralysis during anesthesia.

Normal Reference Ranges

GroupRangeUnit
Adults (serum/pseudocholinesterase)5,320–12,920U/L
RBC acetylcholinesterase26.7–49.2U/g Hb

Reference ranges may vary by laboratory. Always compare results to the ranges provided by your testing facility.

What High ChE Levels Mean

Common Causes

  • Obesity
  • Nephrotic syndrome (increased hepatic protein synthesis)
  • Hyperthyroidism
  • Type 2 diabetes mellitus
  • Coronary artery disease
  • Hyperlipidemia
  • Fatty liver disease

Possible Symptoms

  • No specific symptoms from elevated cholinesterase
  • Symptoms relate to the underlying condition
  • Possible prolonged effect of certain anesthetic drugs is theoretical

What to do: Elevated cholinesterase is generally not a clinical emergency but may point to metabolic conditions warranting evaluation. Check lipid panel, fasting glucose, thyroid function, and liver ultrasound. Manage the underlying condition (weight loss for obesity, statin therapy for hyperlipidemia, thyroid treatment). Elevated cholinesterase has been explored as a marker of metabolic syndrome and cardiovascular risk.

What Low ChE Levels Mean

Common Causes

  • Organophosphate or carbamate pesticide poisoning
  • Nerve agent exposure (sarin, VX)
  • Severe liver disease (cirrhosis, hepatitis, liver failure)
  • Malnutrition and protein-energy wasting
  • Chronic debilitating illness
  • Pseudocholinesterase deficiency (genetic, succinylcholine sensitivity)
  • Pregnancy (mild physiologic decrease)

Possible Symptoms

  • In poisoning: salivation, lacrimation, urination, defecation, emesis (SLUDGE)
  • Miosis (constricted pupils)
  • Muscle fasciculations and weakness
  • Respiratory failure (in severe poisoning)
  • In liver disease: jaundice, edema, ascites
  • Prolonged paralysis after succinylcholine (genetic deficiency)

What to do: In suspected organophosphate poisoning, immediately administer atropine (blocks muscarinic effects) and pralidoxime (reactivates inhibited AChE if given early). Decontaminate the patient. Serial cholinesterase measurements track recovery—RBC AChE reflects tissue recovery better than serum BChE. In liver disease, low cholinesterase indicates severe synthetic dysfunction and carries poor prognosis. For genetic pseudocholinesterase deficiency, document the condition prominently in the medical record, provide a medical alert bracelet, and inform the anesthesia team before any surgery. Dibucaine number testing distinguishes genetic variants.

When Is ChE Testing Recommended?

  • When organophosphate or nerve agent exposure is suspected
  • Before surgery when succinylcholine use is planned
  • When assessing liver synthetic function in chronic liver disease
  • When a family member has known pseudocholinesterase deficiency
  • When monitoring occupational exposure to cholinesterase-inhibiting pesticides

Frequently Asked Questions

Pseudocholinesterase deficiency is a genetic condition in which the enzyme butyrylcholinesterase has reduced activity or is structurally abnormal. Succinylcholine, a short-acting neuromuscular blocker used during anesthesia induction, is normally rapidly hydrolyzed by pseudocholinesterase, limiting paralysis to 5–10 minutes. In patients with pseudocholinesterase deficiency, succinylcholine is not metabolized efficiently, and paralysis—including respiratory muscle paralysis—can last for hours instead of minutes. The most common variant is the "atypical" form, caused by a point mutation that reduces enzyme affinity. The dibucaine number test measures the percentage of enzyme activity inhibited by dibucaine: normal is 70–80%, heterozygous atypical is 40–60%, and homozygous atypical is 15–25%. Prevalence of the homozygous atypical form is approximately 1 in 3,200 in Caucasians.
Organophosphates (found in pesticides like malathion and parathion, and nerve agents like sarin and VX) work by irreversibly inhibiting acetylcholinesterase, the enzyme that breaks down the neurotransmitter acetylcholine at nerve synapses. When AChE is inhibited, acetylcholine accumulates, causing continuous stimulation of both muscarinic receptors (SLUDGE symptoms, bradycardia, bronchospasm) and nicotinic receptors (muscle fasciculations, paralysis). Both RBC AChE and serum BChE are depressed, but they recover at different rates: serum BChE regenerates from liver synthesis in days to weeks, while RBC AChE requires new red blood cell production (months). Serum BChE depression >50% indicates significant exposure; >80% depression indicates severe, life-threatening poisoning.
Cholinesterase (BChE) is exclusively synthesized by the liver, and its serum level directly reflects hepatic synthetic capacity. It has several advantages over other liver synthetic markers: its half-life (~12 days) is shorter than albumin (~20 days), so it declines earlier in acute liver injury. It is not affected by inflammatory states in the same way albumin is (albumin falls as a negative acute-phase reactant regardless of synthetic function). Cholinesterase also does not require vitamin K for its production (unlike coagulation factors). In chronic liver disease, the degree of cholinesterase depression correlates with the severity of cirrhosis and is an independent predictor of mortality. Serial measurements help track disease progression or recovery after acute liver injury.

Related Biomarkers

ALTAlanine AminotransferaseASTAspartate AminotransferaseALBAlbuminTBILBilirubin

Want your ChE levels analyzed?

Upload your lab results for an instant AI-powered breakdown of all your biomarkers.

Upload Lab Results →

Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Reference ranges may vary between laboratories. Always consult your healthcare provider for interpretation of your specific test results.

Disclaimer: SymptomGPT is not a medical diagnosis tool and does not provide medical advice. Always consult a qualified healthcare professional. If you are experiencing a medical emergency, call 911 immediately.